It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Amazon Health Services offers you curated choices, convenience, clarity of cost, and continuity of care on your path to get and stay healthy.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

I f you need to fly with medication, you may have a moment of panic while packing, wondering whether you can take pills or ...

Periods are as natural as colds and fevers. This is a known fact: every woman experiences different kinds of pain and stress ...

The median income for middle-class Americans rose at an average rate of 1.2% per year from 1970 to 2000. The rate slowed to 0.3% per year from 2000 to 2018. The wealth of the top 1% continues to ...

After 3 months, 11 (39% ... Nikka et al., Pers. Comm.]. 1 Department of Neurology, Headache Centre & Pain Neuromodulation Unit, Fondazione Istituto Nazionale Neurologico Carlo Besta, Via Celoria ...

Migraines with brainstem aura are known by several different names: Aura symptoms may last between 5 minutes and 1 hour. When the headache starts, you might feel an intense throbbing or pulsating ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...